Paper77366
Clostridium difficile and the aetiology of pseudomembranous colitis.
Larson HE and 3 others. Lancet, 1978. Cited by 561 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clostridium difficile and the aetiology of pseudomembranous colitis. Papers, record 77366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/77366
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clostridium Infections | Major topic |
| Enterocolitis, Pseudomembranous | Major topic |
| Adult | |
| Animals | |
| Clostridium | |
| Cricetinae | |
| Enterotoxins | |
| Feces | |
| Guinea Pigs | |
| Humans | |
| In Vitro Techniques | |
| Infant, Newborn | |
| Mesocricetus |
Source PubMed
Cited by180
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 561 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,192,717 | Comparison of Phenotypic and Genotypic Antimicrobial Resistances in Bovine Clostridioides difficile Isolates. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42192717 | PubMed |
| 38,399,676 | Reviewing the Clostridioides difficile Mouse Model: Insights into Infection Mechanisms. | Microorganisms | 2024 | https://conductscience.org/library/papers/38399676 | PubMed |
| 38,189,293 | Multimodal vaccination targeting the receptor binding domains of Clostridioides difficile toxins A and B with an attenuated Salmonella Typhimurium vector (YS1646) protects mice from lethal challenge. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38189293 | PubMed |
| 38,175,483 | The ESCMID Study Group for Clostridioides difficile: History, Role, and Perspectives. | Adv Exp Med Biol | 2024 | https://conductscience.org/library/papers/38175483 | PubMed |
| 37,347,682 | A local-scale One Health genomic surveillance of Clostridioides difficile demonstrates highly related strains from humans, canines, and the environment. | Microb Genom | 2023 | https://conductscience.org/library/papers/37347682 | PubMed |
| 36,900,611 | The Environment, Farm Animals and Foods as Sources of Clostridioides difficile Infection in Humans. | Foods | 2023 | https://conductscience.org/library/papers/36900611 | PubMed |
| 35,950,844 | Detection of Plasmid-Mediated Resistance to Metronidazole in Clostridioides difficile from River Water. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/35950844 | PubMed |
| 35,392,442 | Outcomes of Continuous Enteral Vancomycin Infusion in Intensive Care Unit Patients: A Novel Treatment Modality for Severe Clostridium Difficile Colitis. | Cureus | 2022 | https://conductscience.org/library/papers/35392442 | PubMed |
| 35,106,241 | Persistent Clostridium Difficile Diarrhea, Thinking Beyond Pseudomembranous Colitis: A Case Report. | Cureus | 2021 | https://conductscience.org/library/papers/35106241 | PubMed |
| 35,058,787 | Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/35058787 | PubMed |
| 35,001,483 | Clostridioides difficile infection and One Health: an equine perspective. | Environ Microbiol | 2022 | https://conductscience.org/library/papers/35001483 | PubMed |
| 32,721,136 | Clostridium difficile infection in fever patients with gynecological malignancies. | Cancer Rep (Hoboken) | 2019 | https://conductscience.org/library/papers/32721136 | PubMed |
| 32,663,199 | Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies. | JCI Insight | 2020 | https://conductscience.org/library/papers/32663199 | PubMed |
| 32,311,380 | Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper. | Am J Infect Control | 2020 | https://conductscience.org/library/papers/32311380 | PubMed |
| 31,819,461 | Incidence Of Clostridium difficile Infection And Associated Risk Factors Among Hospitalized Children In Qatar. | Ther Clin Risk Manag | 2019 | https://conductscience.org/library/papers/31819461 | PubMed |
| 31,386,902 | Single cell analysis of nutrient regulation of Clostridioides (Clostridium) difficile motility. | Anaerobe | 2019 | https://conductscience.org/library/papers/31386902 | PubMed |
| 31,281,807 | Genomic Delineation of Zoonotic Origins of Clostridium difficile. | Front Public Health | 2019 | https://conductscience.org/library/papers/31281807 | PubMed |
| 31,159,409 | Analysis of Health Benefits Conferred by Lactobacillus Species from Kefir. | Nutrients | 2019 | https://conductscience.org/library/papers/31159409 | PubMed |
| 31,107,202 | A global to local genomics analysis of Clostridioides difficile ST1/RT027 identifies cryptic transmission events in a northern Arizona healthcare network. | Microb Genom | 2019 | https://conductscience.org/library/papers/31107202 | PubMed |
| 30,478,235 | Generation of Markerless Deletions in the Nosocomial Pathogen Clostridium difficile by Induction of DNA Double-Strand Breaks. | Appl Environ Microbiol | 2019 | https://conductscience.org/library/papers/30478235 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/77366
GET https://conductscience.org/api/papers/v1/77366/cited_by?page=2